Join Date
October 2024
Country
Gender
Not Specified
Age
Not Specified
About Adrien Châtillon
I am a serial entrepreneur (3+ startups), who has lived and worked in more than 8 countries.
As the CEO of a medical-tech company, my goal is to democratize access to better and more affordable mental health therapeutics.
As the CEO of a medical-tech company, my goal is to democratize access to better and more affordable mental health therapeutics.
Companies & Work
Actipulse Neuroscience
Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application.
Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment.
Currently in FDA pivotal phase for Major Depressive Disorder, and Pilot phase for Alzheimer's and Parkinson diseases.
Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment.
Currently in FDA pivotal phase for Major Depressive Disorder, and Pilot phase for Alzheimer's and Parkinson diseases.
